Volume | 93,330 |
|
|||||
News | - | ||||||
Day High | 22.59 | Low High |
|||||
Day Low | 21.99 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Fulgent Genetics Inc | FLGT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
22.51 | 21.99 | 22.59 | 22.11 | 22.50 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,732 | 93,330 | $ 22.26 | $ 2,077,442 | - | 19.88 - 44.09 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:20:00 | 13 | $ 22.11 | USD |
Fulgent Genetics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
658.54M | 29.78M | - | 289.21M | -167.83M | -5.63 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Fulgent Genetics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FLGT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 21.66 | 22.91 | 21.5402 | 22.21 | 149,451 | 0.45 | 2.08% |
1 Month | 20.01 | 22.91 | 19.97 | 21.19 | 174,290 | 2.10 | 10.49% |
3 Months | 24.16 | 25.50 | 19.88 | 22.17 | 217,325 | -2.05 | -8.49% |
6 Months | 27.80 | 30.68 | 19.88 | 24.51 | 199,979 | -5.69 | -20.47% |
1 Year | 36.12 | 44.09 | 19.88 | 28.87 | 214,895 | -14.01 | -38.79% |
3 Years | 69.44 | 112.00 | 19.88 | 59.03 | 342,163 | -47.33 | -68.16% |
5 Years | 5.33 | 189.8899 | 4.712 | 59.20 | 514,884 | 16.78 | 314.82% |
Fulgent Genetics Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign. |